Balchem Corporation (BCPC) Income Statement
BCPC 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsBCPC revenue and net income
Where BCPC's revenue goes
2025Each bar shows an amount and its share of revenue. BCPC kept 14.9% of revenue as net income.
BCPC profit margins
BCPC growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +8.8% | +3.2% | +8.1% | +6.5% |
| Gross profit | +10.2% | +9.7% | +10.6% | +8.2% |
| Operating income | +19.4% | +14.6% | +14.5% | +8.8% |
| Net income | +20.5% | +13.7% | +12.8% | +10.0% |
| EPS (diluted) | +17.6% | +8.4% | +9.2% | +8.8% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
BCPC quarterly EPS vs estimates
Balchem beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: October 23, 2026 (estimate $1.53).
BCPC income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.04B | $953.7M | $922.4M | $942.4M | $799.0M | $703.6M | $643.7M | $643.7M | $594.8M | $553.2M |
| Cost of revenue | $666.5M | $617.5M | $620.4M | $661.9M | $555.8M | $479.7M | $432.3M | $439.4M | $405.8M | $372.3M |
| Gross profit | $370.6M | $336.2M | $302.1M | $280.5M | $243.2M | $223.9M | $211.4M | $204.3M | $189.0M | $180.9M |
| Research & development | $18.5M | $16.8M | $15.0M | $12.2M | $13.5M | $10.3M | $11.4M | $11.6M | $9.3M | $7.3M |
| Sales, general & admin | $67.4M | $136.5M | $130.1M | $123.1M | $102.1M | $102.4M | $97.4M | $84.9M | $82.4M | $82.7M |
| Total operating expenses | $152.3M | $153.3M | $142.9M | $135.3M | $115.7M | $112.8M | $108.8M | $96.5M | $91.8M | $90.0M |
| Operating income | $218.3M | $182.9M | $159.2M | $145.2M | $127.5M | $111.1M | $102.6M | $107.1M | $96.9M | $90.8M |
| Interest income | — | — | — | — | — | — | $5.6M | $7.4M | $12,000 | $9,000 |
| Interest expense | $10.2M | $16.5M | $22.6M | $10.3M | $2.5M | $4.4M | $6.0M | $7.6M | $7.5M | $7.3M |
| Income before taxes | $199.0M | $166.5M | $137.3M | $133.7M | $125.2M | $106.4M | $96.5M | $99.0M | $88.5M | $82.9M |
| Income taxes | $44.2M | $38.0M | $28.7M | $28.4M | $29.1M | $21.8M | $16.8M | $20.5M | −$1.6M | $27.0M |
| Net income | $154.8M | $128.5M | $108.5M | $105.4M | $96.1M | $84.6M | $79.7M | $78.6M | $90.1M | $56.0M |
| EBITDA | $254.9M | $231.0M | $214.8M | $195.9M | $176.6M | $162.1M | $148.3M | $151.3M | $140.4M | $136.4M |
| EPS (diluted) | $5.15 | $4.38 | $3.99 | $4.04 | $3.57 | $3.32 | $3.19 | $3.02 | $2.54 | $2.52 |
| Gross margin | 35.7% | 35.3% | 32.7% | 29.8% | 30.4% | 31.8% | 32.8% | 31.7% | 31.8% | 32.7% |
| Operating margin | 21.1% | 19.2% | 17.3% | 15.4% | 16.0% | 15.8% | 15.9% | 16.6% | 16.3% | 16.4% |
| Net margin | 14.9% | 13.5% | 11.8% | 11.2% | 12.0% | 12.0% | 12.4% | 12.2% | 15.1% | 10.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $284.0M | $270.7M | $263.6M | $267.6M | $255.5M | $250.5M | $240.0M | $239.9M | $234.1M | $239.7M | $228.7M | $229.9M |
| Cost of revenue | $180.3M | $169.6M | $169.7M | $172.1M | $162.4M | $162.4M | $153.7M | $154.6M | $151.1M | $158.1M | $153.7M | $153.4M |
| Gross profit | $103.7M | $101.1M | $93.9M | $95.5M | $93.1M | $88.2M | $86.3M | $85.4M | $83.0M | $81.5M | $75.0M | $76.5M |
| Research & development | $4.5M | $5.9M | $5.1M | $9.3M | $4.7M | $4.7M | $4.5M | $4.3M | $3.9M | $4.1M | $3.9M | $3.9M |
| Sales, general & admin | $39.9M | $39.6M | $4.1M | $33.1M | $37.4M | $32.0M | $33.8M | $33.0M | $33.2M | $35.7M | $32.7M | $29.1M |
| Total operating expenses | $44.5M | $45.5M | $33.8M | $40.9M | $41.7M | $37.2M | $38.9M | $37.4M | $37.1M | $39.8M | $36.7M | $32.9M |
| Operating income | $59.2M | $55.6M | $60.1M | $54.6M | $51.4M | $51.0M | $47.4M | $48.0M | $45.8M | $41.7M | $38.3M | $43.6M |
| Interest expense | $1.4M | $3.1M | $2.2M | $2.4M | $2.8M | $2.9M | $2.8M | $4.1M | $4.2M | $5.4M | $5.3M | $6.6M |
| Income before taxes | $57.8M | $52.5M | $50.0M | $52.0M | $49.0M | $47.9M | $44.5M | $43.9M | $41.2M | $36.9M | $33.3M | $36.5M |
| Income taxes | $13.2M | $12.2M | $10.8M | $11.8M | $10.7M | $10.9M | $10.9M | $10.1M | $9.2M | $7.9M | $6.6M | $7.4M |
| Net income | $44.6M | $40.3M | $39.2M | $40.3M | $38.3M | $37.1M | $33.6M | $33.8M | $32.1M | $29.0M | $26.6M | $29.1M |
| EBITDA | $71.4M | $67.2M | $63.9M | $65.9M | $63.2M | $61.9M | $58.2M | $58.9M | $58.0M | $55.9M | $52.6M | $56.9M |
| EPS (diluted) | $1.49 | $1.33 | $1.31 | $1.35 | $1.27 | $1.22 | $1.13 | $1.13 | $1.09 | $1.03 | $0.95 | $1.04 |
| Gross margin | 36.5% | 37.3% | 35.6% | 35.7% | 36.4% | 35.2% | 36.0% | 35.6% | 35.5% | 34.0% | 32.8% | 33.3% |
| Operating margin | 20.9% | 20.5% | 22.8% | 20.4% | 20.1% | 20.4% | 19.8% | 20.0% | 19.6% | 17.4% | 16.8% | 19.0% |
| Net margin | 15.7% | 14.9% | 14.9% | 15.1% | 15.0% | 14.8% | 14.0% | 14.1% | 13.7% | 12.1% | 11.7% | 12.6% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in BCPC's financial statements (latest annual report filed February 20, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
BCPC financial results
In fiscal year 2025 (ended December 31, 2025), Balchem reported revenue of $1.0 billion, up 8.8% from the year before. It had net income of $154.8 million (up 20.5%), a net profit margin of 14.9%. Diluted earnings per share came to $5.15. Over five years revenue grew at an average rate of 8.1% a year.
See the BCPC stock overview for the latest quote and news, or the BCPC chart for price history and technical indicators.
BCPC income statement FAQ
What is Balchem's annual revenue?
Balchem reported total revenue of $1.0 billion for fiscal year 2025, which ended on December 31, 2025. That was up 8.8% from $953.7 million the previous year.
Is Balchem profitable?
Yes. Balchem reported net income of $154.8 million in fiscal 2025, a net profit margin of 14.9%; its operating margin was 21.1%.
What is Balchem's gross margin?
Balchem's gross margin was 35.7% in fiscal 2025: for every $100 of revenue, Balchem kept $36 after the direct cost of its products and services.
How much does Balchem spend on research and development?
Balchem spent $18.5 million on research and development in fiscal 2025, 1.8% of revenue.
How fast is Balchem growing?
Revenue grew 8.1% a year on average over the last five fiscal years, from $703.6 million to $1.0 billion.
What are Balchem's earnings per share?
Balchem earned $5.15 per diluted share in fiscal 2025, compared with $4.38 a year earlier.
When will Balchem report its next earnings?
Balchem is expected to report results for the quarter ending September 30, 2026 on October 23, 2026 before the market opens.
When does Balchem's fiscal year end?
Balchem's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 20, 2026.